congress
presentations
SLEEP 2024
Houston, TX
June 1-5, 2024
Solriamfetol | Excessive Daytime Sleepiness
Dr. Hans P. A. Van Dongen, PhD describes the “Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition” APSS 2024 poster
Solriamfetol | Excessive Daytime Sleepiness
Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition
Solriamfetol | Excessive Daytime Sleepiness
Plenary Presentation: Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition
Solriamfetol | Excessive Daytime Sleepiness
Effects of Solriamfetol on Cognition in Patients With Excessive Daytime Sleepiness Associated With Narcolepsy
Solriamfetol | Excessive Daytime Sleepiness
Plenary Presentation: Effects of Solriamfetol on Cognition in Patients With Excessive Daytime Sleepiness Associated With Narcolepsy
Solriamfetol | Excessive Daytime Sleepiness
SURWEY: Treatment of Excessive Daytime Sleepiness With Solriamfetol: Initiation, Titration, and Outcomes
Solriamfetol | Excessive Daytime Sleepiness
Real-world Use of Solriamfetol for Excessive Daytime Sleepiness in Patients Reporting Anxiety or Depression
Solriamfetol | Excessive Daytime Sleepiness